S. Di Martino

Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review

G. Docimo, M. Montella, M. Mascolo, 2019, BMC Endocrine Disorders.

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?

G. Docimo, R. Patrone, G. Conzo, 2019, BMC Endocrine Disorders.

Pregnancy may favour the development of severe autoimmune central diabetes insipidus in women with vasopressin cell antibodies: description of two cases.

G. Bellastella, K. Esposito, A. De Bellis, 2015, European journal of endocrinology.

Association of arginine vasopressin-secreting cell, steroid-secreting cell, adrenal and islet cell antibodies in a patient presenting with central diabetes insipidus, empty sella, subclinical adrenocortical failure and impaired glucose tolerance.

S. Savastano, A. Bellastella, A. De Bellis, 1995, Hormone research.

Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves’ disease

G. Bellastella, A. Bellastella, A. De Bellis, 2004, Clinical endocrinology.

Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy.

A. Bellastella, A. De Bellis, A. Sinisi, 1998, The Journal of clinical endocrinology and metabolism.

Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.

A. Bellastella, A. De Bellis, A. Sinisi, 1995, The Journal of clinical endocrinology and metabolism.

Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos.

L. Mansi, P. Rambaldi, A. De Bellis, 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.